In the last three months, Zimmer Biomet has been trading below the Zacks categorized Medical - Products industry on factors like macroeconomic uncertainties, pricing pressure and unfavorable currency fluctuations. The stock till now has lost 4.2%, wider than the broader industry's 2.8% decline.